These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37268438)

  • 1. Paperwork, Paradox, and PRN: Psychotropic Medication Deficiencies in Assisted Living.
    Dys S; Carder P
    J Appl Gerontol; 2023 Nov; 42(11):2198-2206. PubMed ID: 37268438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the Medication Pass: Attitudes, Ethics, Agency, and Antipsychotic Medications in Assisted Living/Residential Care.
    Dys S; Carder P
    Innov Aging; 2022; 6(6):igac052. PubMed ID: 36452047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. As-Needed Prescribing and Administration of Psychotropic Medications in Assisted Living: A 7-State Study.
    Carder P; Zimmerman S; Wretman CJ; Preisser JS; Dys S; Sloane PD
    J Am Med Dir Assoc; 2022 Jun; 23(6):1038-1044.e3. PubMed ID: 34919835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral symptoms in residential care/assisted living facilities: prevalence, risk factors, and medication management.
    Gruber-Baldini AL; Boustani M; Sloane PD; Zimmerman S
    J Am Geriatr Soc; 2004 Oct; 52(10):1610-7. PubMed ID: 15450035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia.
    Yoon JM; Trinkoff AM; Galik E; Storr CL; Lerner NB; Brandt N; Zhu S
    J Am Med Dir Assoc; 2022 Nov; 23(11):1772-1779. PubMed ID: 35568094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey Deficiencies as Quality Indicators in Oregon Assisted Living Communities.
    Tunalilar O; Lin S; Carder P
    Gerontologist; 2022 Sep; 62(8):1124-1134. PubMed ID: 34865025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health nurses' PRN psychotropic medication administration practices.
    Usher K; Lindsay D; Sellen J
    J Psychiatr Ment Health Nurs; 2001 Oct; 8(5):383-90. PubMed ID: 11882157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Regulatory Approaches for Dementia Care in Residential Care and Assisted Living.
    Carder PC
    Gerontologist; 2017 Aug; 57(4):776-786. PubMed ID: 28077453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Learning about your residents": how assisted living residence medication aides decide to administer pro re nata medications to persons with dementia.
    Carder PC
    Gerontologist; 2012 Feb; 52(1):46-55. PubMed ID: 21903615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.
    Baker JA; Lovell K; Harris N
    Gen Hosp Psychiatry; 2007; 29(2):163-8. PubMed ID: 17336666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership.
    Coe AB; Zhang T; Zullo AR; Gerlach LB; Thomas KS; Daiello LA; Varma H; Lo D; Joshi R; Shireman TI; Bynum JPW
    J Am Geriatr Soc; 2022 Dec; 70(12):3513-3525. PubMed ID: 35984088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documentation of psychotropic pro re nata medication administration: An evaluation of electronic health records compared with paper charts and verbal reports.
    Martin K; Ham E; Hilton NZ
    J Clin Nurs; 2018 Aug; 27(15-16):3171-3178. PubMed ID: 29752835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses' use of pro re nata medication in adult acute mental healthcare settings: An integrative review.
    Wong S; Müller A
    Int J Ment Health Nurs; 2023 Oct; 32(5):1243-1258. PubMed ID: 37025073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Psychotropic PRN Medications in a Canadian Psychiatric Intensive Care Unit.
    Casol M; Tong A; Ng JCY; McGloin R
    J Am Psychiatr Nurses Assoc; 2023; 29(2):103-111. PubMed ID: 34109871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study.
    Harrison SL; Bradley C; Milte R; Liu E; Kouladjian O'Donnell L; Hilmer SN; Crotty M
    BMC Geriatr; 2018 Feb; 18(1):60. PubMed ID: 29478410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Function-Focused Care on Psychotropic Medications and Opioid Use Among Assisted Living Residents.
    Resnick B; Galik E; Boltz M
    Sr Care Pharm; 2022 Mar; 37(3):87-95. PubMed ID: 35197151
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
    Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.